(Q30829255)

26 June 2017

1 reference

title

TGF-beta signaling from receptors to the nucleus (English)

1 reference

26 June 2017

A B Roberts

1

1 reference

26 June 2017

1 December 1999

1 reference

26 June 2017

Microbes and Infection

1 reference

26 June 2017

1

1 reference

26 June 2017

1265-1273

1 reference

26 June 2017

15

1 reference

Regulation of immune responses by TGF-beta

26 June 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2900258-0

7 January 2021

Smads: transcriptional activators of TGF-beta responses

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2900258-0

7 January 2021

TGF-beta signal transduction

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2900258-0

7 January 2021

TGF-beta signaling, Smads, and tumor suppressors.

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2900258-0

7 January 2021

STATs and gene regulation

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2900258-0

7 January 2021

TGF-beta signalling from cell membrane to nucleus through SMAD proteins

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2900258-0

7 January 2021

Mads and Smads in TGF beta signalling

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2900258-0

7 January 2021

Assignment of transforming growth factor beta1 and beta3 and a third new ligand to the type I receptor ALK-1

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2900258-0

7 January 2021

TGF-beta receptor-mediated signalling through Smad2, Smad3 and Smad4

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2900258-0

7 January 2021

MADR2 maps to 18q21 and encodes a TGFbeta-regulated MAD-related protein that is functionally mutated in colorectal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2900258-0

7 January 2021

Signal transduction by bone morphogenetic proteins

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2900258-0

7 January 2021

TbetaRI phosphorylation of Smad2 on Ser465 and Ser467 is required for Smad2-Smad4 complex formation and signaling

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2900258-0

7 January 2021

Phosphorylation of Ser465 and Ser467 in the C terminus of Smad2 mediates interaction with Smad4 and is required for transforming growth factor-beta signaling

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2900258-0

7 January 2021

Determinants of specificity in TGF-beta signal transduction.

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2900258-0

7 January 2021

Mutations increasing autoinhibition inactivate tumour suppressors Smad2 and Smad4.

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2900258-0

7 January 2021

SARA, a FYVE domain protein that recruits Smad2 to the TGFbeta receptor

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2900258-0

7 January 2021

DPC4, a candidate tumor suppressor gene at human chromosome 18q21.1

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2900258-0

7 January 2021

Partnership between DPC4 and SMAD proteins in TGF-beta signalling pathways.

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2900258-0

7 January 2021

A structural basis for mutational inactivation of the tumour suppressor Smad4

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2900258-0

7 January 2021

Smad proteins exist as monomers in vivo and undergo homo- and hetero-oligomerization upon activation by serine/threonine kinase receptors

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2900258-0

7 January 2021

Mutations in the SMAD4/DPC4 gene in juvenile polyposis

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2900258-0

7 January 2021

Characterization of functional domains within Smad4/DPC4

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2900258-0

7 January 2021

Vascular MADs: two novel MAD-related genes selectively inducible by flow in human vascular endothelium

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2900258-0

7 January 2021

Smad6 inhibits signalling by the TGF-beta superfamily.

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2900258-0

7 January 2021

Identification of Smad7, a TGFbeta-inducible antagonist of TGF-beta signalling

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2900258-0

7 January 2021

Signaling through scaffold, anchoring, and adaptor proteins

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2900258-0

7 January 2021

Daughters against dpp modulates dpp organizing activity in Drosophila wing development.

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2900258-0

7 January 2021

Twenty proteins containing a C-terminal SOCS box form five structural classes

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2900258-0

7 January 2021

Induction of inhibitory Smad6 and Smad7 mRNA by TGF-beta family members

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2900258-0

7 January 2021

Transforming growth factor beta1 induces nuclear export of inhibitory Smad7

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2900258-0

7 January 2021

SMAD3/4-dependent transcriptional activation of the human type VII collagen gene (COL7A1) promoter by transforming growth factor beta.

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2900258-0

7 January 2021

Alternatively spliced variant of Smad2 lacking exon 3. Comparison with wild-type Smad2 and Smad3.

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2900258-0

7 January 2021

Human Smad3 and Smad4 are sequence-specific transcription activators

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2900258-0

7 January 2021

Synergistic cooperation of TFE3 and smad proteins in TGF-beta-induced transcription of the plasminogen activator inhibitor-1 gene

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2900258-0

7 January 2021

Direct binding of Smad3 and Smad4 to critical TGF beta-inducible elements in the promoter of human plasminogen activator inhibitor-type 1 gene

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2900258-0

7 January 2021

Smad4/DPC4 and Smad3 mediate transforming growth factor-beta (TGF-beta) signaling through direct binding to a novel TGF-beta-responsive element in the human plasminogen activator inhibitor-1 promoter

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2900258-0

7 January 2021

Identification and functional characterization of a Smad binding element (SBE) in the JunB promoter that acts as a transforming growth factor-beta, activin, and bone morphogenetic protein-inducible enhancer.

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2900258-0

7 January 2021

Tumor suppressor Smad4 is a transforming growth factor beta-inducible DNA binding protein

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2900258-0

7 January 2021

Crystal structure of a Smad MH1 domain bound to DNA: insights on DNA binding in TGF-beta signaling

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2900258-0

7 January 2021

Smad4 and FAST-1 in the assembly of activin-responsive factor

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2900258-0

7 January 2021

Smad3 and Smad4 cooperate with c-Jun/c-Fos to mediate TGF-beta-induced transcription

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2900258-0

7 January 2021

The oncoprotein Evi-1 represses TGF-beta signalling by inhibiting Smad3

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2900258-0

7 January 2021

Regulation of the human p21/WAF1/Cip1 promoter in hepatic cells by functional interactions between Sp1 and Smad family members

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2900258-0

7 January 2021

The tumor suppressor Smad4/DPC4 and transcriptional adaptor CBP/p300 are coactivators for smad3 in TGF-beta-induced transcriptional activation

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2900258-0

7 January 2021

CREB binding protein is a required coactivator for Smad-dependent, transforming growth factor beta transcriptional responses in endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2900258-0

7 January 2021

Transcriptional activating activity of Smad4: roles of SMAD hetero-oligomerization and enhancement by an associating transactivator

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2900258-0

7 January 2021

Opposing BMP and EGF signalling pathways converge on the TGF-beta family mediator Smad1

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2900258-0

7 January 2021

Smad2 transduces common signals from receptor serine-threonine and tyrosine kinases

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2900258-0

7 January 2021

Mice lacking Smad3 show accelerated wound healing and an impaired local inflammatory response

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2900258-0

7 January 2021

Smad2 signaling in extraembryonic tissues determines anterior-posterior polarity of the early mouse embryo

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2900258-0

7 January 2021

Smad2 role in mesoderm formation, left-right patterning and craniofacial development

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2900258-0

7 January 2021

The tumor suppressor gene Smad4/Dpc4 is required for gastrulation and later for anterior development of the mouse embryo

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2900258-0

7 January 2021

10.1016/S1286-4579(99)00258-0

Identifiers

DOI

1 reference

26 June 2017

1 reference

PubMed ID

10611754